Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06404047 · ClinicalTrials.gov registry record · NA
RECOVER-ENERGIZE Platform Protocol
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 660
- Enrollment target
NCT06404047: Completed NA study, sponsored by Duke University.
NCT06404047 is a NA study that has completed, run by Duke University. The registered enrollment target is 660 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (53% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06404047, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 660 participants
- Enrollment target
Study Summary
This is a platform protocol designed to be flexible so that it is suitable for a range of interventions and settings within diverse health care systems and community settings with incorporation into clinical COVID-19 management programs and treatment plans if results achieve key study outcomes. This protocol is a prospective, multi-center, multi-arm, randomized, controlled platform trial evaluating interventions to address and improve exercise intolerance and post-exertional malaise (PEM) as manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC). The focus of this protocol is to assess interventions that can improve exercise capacity, daily activities tolerance, and quality of life in patients with PASC.
Primary Outcome
Total number of participants enrolled in each Appendix will be reported. Appendix-specific outcome measure data will be reported under the associated NCT#
Interventions
- OTHER Usual Care
- OTHER Education
- BEHAVIORAL Personalized Cardiopulmonary Rehabilitation
- BEHAVIORAL Structured Pacing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 660 participants |
| Start Date | 2024-07-17 |
| Est. Completion | 2025-10-30 |
| Phase | NA |
What the finished NCT06404047 record still lists
NCT06404047 is an interventional study that assigns participants to a tested intervention. The registered 660 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (53% lower).
The record links to 0 conditions, and to 4 interventions - of which Usual Care is the first listed.
NCT06404047 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06404047 about?
NCT06404047 is a clinical study titled "RECOVER-ENERGIZE Platform Protocol". This is a platform protocol designed to be flexible so that it is suitable for a range of interventions and settings within diverse health care systems and community settings with incorporation into clinical COVID-19 management programs and treatment plans if results achieve key study outcomes. Thi...
What is the current status of trial NCT06404047?
This trial is currently completed. It is a NA study. The enrollment target is 660 participants. The study started on 2024-07-17. Estimated completion is 2025-10-30.
What interventions are being tested in trial NCT06404047?
The interventions under investigation include: Usual Care (OTHER), Education (OTHER), Personalized Cardiopulmonary Rehabilitation (BEHAVIORAL), Structured Pacing (BEHAVIORAL).
Who is sponsoring clinical trial NCT06404047?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06404047's enrollment target sits among peer trials
660 155th of 2000 higher than 1,845 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01185132 · 660 participants · Phase 3
Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy
- NCT03346694 · 660 participants · NA
Reducing Surgical Site Infection Rates Using an Alternative Sternal Dressing
- NCT05407636 · 660 participants · Phase 3
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
- NCT05470205 · 660 participants · Phase 3
Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension; Renewal
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI